{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/L",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS" , "@language" : "en" } ,        { "@value" : "Cytostatika a imunomodula\u010Dn\u00ED l\u00E9\u010Diva" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L01",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Cytostatika" , "@language" : "cs" } ,        { "@value" : "ANTINEOPLASTIC AGENTS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L01" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L01A",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "ALKYLATING AGENTS" , "@language" : "en" } ,        { "@value" : "Alkyla\u010Dn\u00ED l\u00E1tky" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L01A" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L01AA",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Nitrogen mustard analogues" , "@language" : "en" } ,        { "@value" : "Analogy dus\u00EDkat\u00E9ho yperitu" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L01AA" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/L01AA09",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/L01AA" ,        "http://linked.opendata.cz/resource/ATC/L" ,        "http://linked.opendata.cz/resource/ATC/L01" ,        "http://linked.opendata.cz/resource/ATC/L01A" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Bendamustine" , "@language" : "en" } ,        { "@value" : "Bendamustin" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "L01AA09" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0307744",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Bendamustine hydrochloride" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/LEVACT-2-5-MG-ML",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0307744" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "LEVACT 2,5 MG/ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L01AA09" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0179308" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0179307" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0179306" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0179310" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0179308",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "LEVACT 2,5 MG/ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L01AA09" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC138373_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "20" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Infuze" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba prvn\u00ED linie chronick\u00E9 lymfocyt\u00E1rn\u00ED leuk\u00E9mie (st\u00E1dia B nebo C dle Bineta) u\u00A0pacient\u016F, pro kter\u00E9 nen\u00ED vhodn\u00E1 kombinovan\u00E1 chemoterapie obsahuj\u00EDc\u00ED fludarabin.\nV\u00A0monoterapii k\u00A0l\u00E9\u010Db\u011B indolentn\u00EDho non-Hodgkinova lymfomu u\u00A0pacient\u016F, kte\u0159\u00ED progredovali b\u011Bhem l\u00E9\u010Dby rituximabem nebo re\u017Eimem zahrnuj\u00EDc\u00EDm rituximab nebo b\u011Bhem 6\u00A0m\u011Bs\u00EDc\u016F po takov\u00E9 l\u00E9\u010Db\u011B.\nL\u00E9\u010Dba prvn\u00ED linie mnoho\u010Detn\u00E9ho myelomu (st\u00E1dia II s\u00A0progres\u00ED nebo st\u00E1dia III dle Durie-Salmona) v\u00A0kombinaci s\u00A0prednisonem u\u00A0pacient\u016F star\u0161\u00EDch 65\u00A0let, pro kter\u00E9 nen\u00ED vhodn\u00E1 autologn\u00ED transplantace kmenov\u00FDch bun\u011Bk a kte\u0159\u00ED v\u00A0dob\u011B diagn\u00F3zy trp\u00ED klinickou neuropati\u00ED, co\u017E vylu\u010Duje pou\u017Eit\u00ED terapie obsahuj\u00EDc\u00ED thalidomid nebo bortezomib.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasResumedMarketingDate" : [ { "@value" : "2012-01-11" , "@type" : "http://www.w3.org/2001/XMLSchema#date" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 40486.12890625 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 38554.16015625 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INF PLV CSL 20X25MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0179307",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "LEVACT 2,5 MG/ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L01AA09" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC138373_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "10" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Infuze" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba prvn\u00ED linie chronick\u00E9 lymfocyt\u00E1rn\u00ED leuk\u00E9mie (st\u00E1dia B nebo C dle Bineta) u\u00A0pacient\u016F, pro kter\u00E9 nen\u00ED vhodn\u00E1 kombinovan\u00E1 chemoterapie obsahuj\u00EDc\u00ED fludarabin.\nV\u00A0monoterapii k\u00A0l\u00E9\u010Db\u011B indolentn\u00EDho non-Hodgkinova lymfomu u\u00A0pacient\u016F, kte\u0159\u00ED progredovali b\u011Bhem l\u00E9\u010Dby rituximabem nebo re\u017Eimem zahrnuj\u00EDc\u00EDm rituximab nebo b\u011Bhem 6\u00A0m\u011Bs\u00EDc\u016F po takov\u00E9 l\u00E9\u010Db\u011B.\nL\u00E9\u010Dba prvn\u00ED linie mnoho\u010Detn\u00E9ho myelomu (st\u00E1dia II s\u00A0progres\u00ED nebo st\u00E1dia III dle Durie-Salmona) v\u00A0kombinaci s\u00A0prednisonem u\u00A0pacient\u016F star\u0161\u00EDch 65\u00A0let, pro kter\u00E9 nen\u00ED vhodn\u00E1 autologn\u00ED transplantace kmenov\u00FDch bun\u011Bk a kte\u0159\u00ED v\u00A0dob\u011B diagn\u00F3zy trp\u00ED klinickou neuropati\u00ED, co\u017E vylu\u010Duje pou\u017Eit\u00ED terapie obsahuj\u00EDc\u00ED thalidomid nebo bortezomib.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INF PLV CSL 10X25MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0179306",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "LEVACT 2,5 MG/ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L01AA09" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC138373_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "5" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Infuze" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba prvn\u00ED linie chronick\u00E9 lymfocyt\u00E1rn\u00ED leuk\u00E9mie (st\u00E1dia B nebo C dle Bineta) u\u00A0pacient\u016F, pro kter\u00E9 nen\u00ED vhodn\u00E1 kombinovan\u00E1 chemoterapie obsahuj\u00EDc\u00ED fludarabin.\nV\u00A0monoterapii k\u00A0l\u00E9\u010Db\u011B indolentn\u00EDho non-Hodgkinova lymfomu u\u00A0pacient\u016F, kte\u0159\u00ED progredovali b\u011Bhem l\u00E9\u010Dby rituximabem nebo re\u017Eimem zahrnuj\u00EDc\u00EDm rituximab nebo b\u011Bhem 6\u00A0m\u011Bs\u00EDc\u016F po takov\u00E9 l\u00E9\u010Db\u011B.\nL\u00E9\u010Dba prvn\u00ED linie mnoho\u010Detn\u00E9ho myelomu (st\u00E1dia II s\u00A0progres\u00ED nebo st\u00E1dia III dle Durie-Salmona) v\u00A0kombinaci s\u00A0prednisonem u\u00A0pacient\u016F star\u0161\u00EDch 65\u00A0let, pro kter\u00E9 nen\u00ED vhodn\u00E1 autologn\u00ED transplantace kmenov\u00FDch bun\u011Bk a kte\u0159\u00ED v\u00A0dob\u011B diagn\u00F3zy trp\u00ED klinickou neuropati\u00ED, co\u017E vylu\u010Duje pou\u017Eit\u00ED terapie obsahuj\u00EDc\u00ED thalidomid nebo bortezomib.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INF PLV CSL 5X25MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0179310",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "LEVACT 2,5 MG/ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/L01AA09" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "CYTOSTATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC138373_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "5" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Infuze" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "2.5MG/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "L\u00E9\u010Dba prvn\u00ED linie chronick\u00E9 lymfocyt\u00E1rn\u00ED leuk\u00E9mie (st\u00E1dia B nebo C dle Bineta) u\u00A0pacient\u016F, pro kter\u00E9 nen\u00ED vhodn\u00E1 kombinovan\u00E1 chemoterapie obsahuj\u00EDc\u00ED fludarabin.\nV\u00A0monoterapii k\u00A0l\u00E9\u010Db\u011B indolentn\u00EDho non-Hodgkinova lymfomu u\u00A0pacient\u016F, kte\u0159\u00ED progredovali b\u011Bhem l\u00E9\u010Dby rituximabem nebo re\u017Eimem zahrnuj\u00EDc\u00EDm rituximab nebo b\u011Bhem 6\u00A0m\u011Bs\u00EDc\u016F po takov\u00E9 l\u00E9\u010Db\u011B.\nL\u00E9\u010Dba prvn\u00ED linie mnoho\u010Detn\u00E9ho myelomu (st\u00E1dia II s\u00A0progres\u00ED nebo st\u00E1dia III dle Durie-Salmona) v\u00A0kombinaci s\u00A0prednisonem u\u00A0pacient\u016F star\u0161\u00EDch 65\u00A0let, pro kter\u00E9 nen\u00ED vhodn\u00E1 autologn\u00ED transplantace kmenov\u00FDch bun\u011Bk a kte\u0159\u00ED v\u00A0dob\u011B diagn\u00F3zy trp\u00ED klinickou neuropati\u00ED, co\u017E vylu\u010Duje pou\u017Eit\u00ED terapie obsahuj\u00EDc\u00ED thalidomid nebo bortezomib.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasResumedMarketingDate" : [ { "@value" : "2012-01-11" , "@type" : "http://www.w3.org/2001/XMLSchema#date" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 39955.26953125 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 38554.16015625 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INF PLV CSL 5X100MG" , "@language" : "cs" } ] }] }